Characterization of the SARS-CoV-2 B.1.621 (Mu) variant
Author(s) -
Peter Halfmann,
Makoto Kuroda,
Tammy Armbrust,
James Theiler,
Ariane Balaram,
Gage K. Moreno,
Molly A. Accola,
Kiyoko IwatsukiHorimoto,
Riccardo Valdez,
Emily Stoneman,
Katarina M. Braun,
Seiya Yamayoshi,
Elizabeth D. Somsen,
John J. Baczenas,
Keiko Mitamura,
Masao Hagihara,
Eisuke Adachi,
Michiko Koga,
Matthew T. McLaughlin,
William M. Rehrauer,
Masaki Imai,
Shinya Yamamoto,
Takeya Tsutsumi,
Makoto Saito,
Thomas C. Friedrich,
Shelby L. O’Connor,
David H. O’Connor,
Aubree Gordon,
Bette Korber,
Yoshihiro Kawaoka
Publication year - 2022
Publication title -
science translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.819
H-Index - 216
eISSN - 1946-6242
pISSN - 1946-6234
DOI - 10.1126/scitranslmed.abm4908
Subject(s) - neutralization , titer , antibody , virology , vaccination , neutralizing antibody , antibody titer , medicine , biology , plaque reduction neutralization test , virus , immunology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom